SC
Stempoint Capital Portfolio holdings
AUM
$311M
This Quarter Return
-9.67%
1 Year Return
+15.22%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$340M
AUM Growth
+$340M
(-9.2%)
Cap. Flow
-$481K
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
55.44%
Holding
66
New
16
Increased
14
Reduced
10
Closed
19
Top Buys
| 1 |
Immunocore
IMCR
|
$11.5M |
| 2 |
Immunovant
IMVT
|
$10.2M |
| 3 |
Merck
MRK
|
$10.2M |
| 4 |
GSK
GSK
|
$9.47M |
| 5 |
Arcellx
ACLX
|
$7.75M |
Top Sells
| 1 |
Insmed
INSM
|
$12.4M |
| 2 |
Eli Lilly
LLY
|
$11.7M |
| 3 |
Arcutis Biotherapeutics
ARQT
|
$11.5M |
| 4 |
Roivant Sciences
ROIV
|
$8.89M |
| 5 |
Tarsus Pharmaceuticals
TARS
|
$8.08M |
Sector Composition
| 1 | Healthcare | 99.56% |
| 2 | Financials | 0.44% |
